New Search

If you are not happy with the results below please do another search

12 search results for:

3

Large Grant: “Modifying the Automatic Approach Bias toward Gambling Stimuli in Problem Gamblers: A Novel Intervention for Changing Excessive Gambling Behavior”

Principal Investigator: Sherry H. Stewart, PhD, Dalhousie University
Awarded $172,500 in 2014

Aim: Understand the implicit thought patterns that could play a role in the development of a gambling disorder, by exploring whether or not disordered gamblers have an “approach bias” (i.e. the automatic tendency to approach or conduct a risky-behavior rather than avoid it).

7

Seed Grant: “Assessing Risk-preference and Compulsive Behavior in a Rodent Gambling Task”

Principal Investigator: Jamie Donahey Roitman, PhD, University of Illinois at Chicago
Awarded $34,500 in 2014

Aim: Devise an animal model of disordered gambling to understand the extent to which risky decision-making processes are innate or altered by experience; how different patterns of neural activity drive behavior toward risk-seeking or avoidance; and how therapeutic methods can alter neural activity to reduce disordered gambling behavior.

9

Travel Grant: “Rapid Intermittent Deep Brain Stimulation Biases Behavior in a Financial Decision-making Task”

Principal Investigator: Shaun Patel, PhD, Massachusetts General Hospital
Awarded $1,500 in 2014

The Travel Grant supported Dr. Patel’s participation in the poster session at the annual meeting of the Society for Neuroscience, where he presented on a study of patients undergoing deep brain stimulation while engaged in a financial decision-making task.

10

Travel Grant: “Effects of Mixed-Function Serotonergic Compounds in a Novel Rodent Cost/Benefit Decision-Making Task”

Principal Investigator: Amanda Persons, PhD, Rush University Medical Center
Awarded $1,294 in 2014

The Travel Grant supported Dr. Person’s participation in the poster session at the 2014 annual meeting of the Society for Neuroscience. Her study tested the impact of a serotonergic medication on decision making, using a novel rat model of cost/benefit decision making.